Biochemistry & Cancer Biology

2011-2012 Cancer Biology Seminar Series                                                                                                Director:  Kathryn M. Eisenmann, Ph.D.

October 27, 2011
"FXYD Proteins as Regulators of Cell Physiology"
Kathleen J. Sweadner, Ph.D., Associate Professor, Cellular and Molecular Physiology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA
4:00 pm, HEB 105

November 17, 2011
"tRNA Synthetase Inhibition Mediates the Anti-Inflammatory and Anti-fibrotic Activities of the Natural Product Derivative Halofuginone"
Malcolm Whitman, Ph.D., Professor, Dept. of Developmental Biology (Cell Biology), Harvard Medical School/Harvard School of Dental Medicine, Boston, MA
4:00 pm, HEB 105

January 12, 2012
"Ouabain, a Hormone with Effects on Polycystic Kidney Disease"
Victor Gustavo Blanco, Ph.D., Associate Professor, Dept. of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS
4:00 pm, HEB 105

January 19, 2012
"Don't Dump the Pumps:  Na+, K+-ATPase Surface Abundance and Ischemia-Reperfusion Injury"
Sandrine V. Pierre, Ph.D., Assistant Professor, Dept. of Physiology & Pharmacology, The University of Toledo College of Medicine
4:00 pm, HEB 105

January 26, 2012
"The Interaction of Cardiac Steroids with the Na+, K+-ATPase - A Potential Target for Anti-Cancer Therapy"
David Lichtstein, Ph.D., Professor, Chairman, Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel
4:00 pm, HEB 105

February 2, 2012
"Inflammatory IL-6 Feedback Loop Regulates Breast Cancer Stem Cells Which Mediate Therapeutic Resistance" 
Hasan Korkaya, Ph.D., Research Assistant Professor, Dept. of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI
4:00 pm, HEB 105

February 16, 2012
"New Insights on the Role of EZH2 in Breast Tumorigenesis"
Celina G. Kleer, M.D., Director, Breast Pathology Section and Fellowship, Harold A. Oberman Collegiate Professor of Pathology, University of Michigan, Ann Arbor, MI
4:00 pm, HEB 105 

February 23, 2012
"RARa as a Potential Drug Target to Improve the Outcome of Hormonal Adjuvant Therapy in Breast Cancer"
Venkatesh Chari, Graduate Research Assistant (Cancer Biology track), Dept. of Biochemistry & Cancer Biology, University of Toledo College of Medicine
4:00 pm, HEB 105

March 1, 2012
"Role of Base Excision Repair and Mismatch Repair in Mediating Cisplatin Sensitivity"
Akshada Sawant, Graduate Research Assistant (Cancer Biology track), Dept. of Biochemistry & Cancer Biology, University of Toledo College of Medicine
4:00 pm, HEB 105

March 15, 2012
"Context Dependent Membrane Bending:  An F-BAR Protein in Neurons and Non-Neuronal Cells"
Erik Dent, Ph.D., Assistant Professor, Dept. of Neuroscience, University of Wisconsin, School of Medicine & Public Health, Madison, WI
4:00 pm, HEB 105

March 21, 2012
"Rad18 Changes Tunes for Different DNA Damage Responses"
Komaraiah Palle, Ph.D., Research Associate, Department of Pathology and Laboratory Medicine, University of NC at Chapel Hill, Chapel Hill, NC
(Candidate for Faculty Position)
4:00 pm, BHS 436

March 22, 2012
"Novel Glucagon Peptides that Demonstrate the Virtues of Combinatorial Pharmacology in the Treatment of Obesity and Diabetes"
Co-Sponsor with Center for Diabetes & Endocrine Research (CeDER)
Richard DiMarchi, Ph.D., Standiford H. Cox Professor of Chemistry, Linda & Jack Gill Chair in Biomolecular Sciences, Indiana University, Department of Chemistry, Bloomington, IN
4:00 pm, HEB 105

March 26, 2012
"Control of iNKT Cell Development by c-Myb and the RAS/MAPK Cascade"
Taishan Hu, Ph.D., Research Assistant Member, Immunobiology & Cancer Research Program, OK Medical Research Foundation, Oklahoma City, OK
(Candidate for Faculty Position)
4:00 pm, BHS 436

April 5, 2012
"The Role of CRL4-Cdt2 in Cell Cycle Progression and Genome Instability"
Tarek A. Abbas, Ph.D., Assistant Professor of Research, Department of Biochemistry and Molecular Genetics, University of Virginia, School of Medicine, Charlottesville, VA
(Candidate for Faculty Position)
4:00 pm, BHS 436

April 9, 2012
"Control of iNKT Cell Development by c-Myb and the RAS/MAPK Cascade"
Suling Liu, Ph.D., Research Assistant Professor, Department of Internal Medicine, Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI
(Candidate for Faculty Position)
4:00 pm, BHS 436

April 12, 2012
"From the Lab to the Legislature:  Scientists as Science Advocates"
Co-Sponsored with Graduate School & Department of Physiology & Pharmacology & CVMD Graduate Program
Jennifer A. Hobin, Ph.D., Director of Science Policy, Office of Public Affairs, Federation of American Societies for Experimental Biology, Bethesda, MD
4:00 pm, HEB 105

April 16, 2012
"Targeting HIF1a Eliminates Cancer Stem Cells in Hematological Malignancies"
Yin Wang, Ph.D., Research Assistant Professor, Department of Surgery, The University of Michigan, Ann Arbor, MI
(Candidate for Faculty Position)
4:00 pm, BHS 436

April 19, 2012
"Molecular Diagnostic Tests to Augment Cytomorphologic Diagnosis of Lung Cancer Trans-Thoracic Fine Needle Aspirate Samples"
Jiyoun Yeo, Graduate Research Assistant (Cancer Biology track), Dept. of Medicine, University of Toledo College of Medicine
4:00 pm, HEB 105

April 26, 2012
"Role of EgIN2 Prolyl Hydroxylase in Breast Cancer"
Qing Zhang, Ph.D., Instructor, Dana Farber Cancer Institute, Boston, MA
(Candidate for Faculty Position)
4:00 pm, BHS 436

May 2, 2012
"Development of Targeted Therapy for ERK Pathway in Triple-Negative Breast Cancer"
Chandra Bartholomeusz, M.D., Ph.D., Assistant Professor, Department of Breast Medical Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX
(Candidate for Faculty Position)
4:00 pm, BHS 436 

May 3, 2012
"Mechanism Based Approach to Improving Tamoxifen Adjuvant Therapy in Breast Cancer"
Mugdha Patki, Graduate Research Assistant (Cancer Biology track), Dept. of Biochemistry & Cancer Biology, University of Toledo College of Medicine
4:00 pm, HEB 105

May 10, 2012
"Targeting and Modeling Glioblastoma Stem Cells"
Anita Hjelmeland, Ph.D., Assistant Professor of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH
4:00 pm, HEB 105

May 17 2012
"Synthesis and Characterization of Indole-based Chalcones as an Inducers of Non-apoptotoic Cell Death"
Michael Robinson, M.D., Ph.D. Candidate (Cancer Biology track), Dept. of Biochemistry & Cancer Biology, University of Toledo College of Medicine
4:00 pm, HEB 105

May 24, 2012
"CXCL12 and the DIP:mDia2 Axis in Breast Cancer Morphology and Motility"
Meghan Wyse, Graduate Research Assistant (Cancer Biology track), Dept. of Biochemistry & Cancer Biology, Universitiy of Toledo College of Medicine
4:00 pm, HEB 105









Last Updated: 6/26/15